Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$0.27.

  • GeneDx Holdings' EPS (Basic) rose 1290.32% to -$0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.11, marking a year-over-year increase of 10353.7%. This contributed to the annual value of -$1.94 for FY2024, which is 7310.72% up from last year.
  • Latest data reveals that GeneDx Holdings reported EPS (Basic) of -$0.27 as of Q3 2025, which was up 1290.32% from $0.38 recorded in Q2 2025.
  • GeneDx Holdings' 5-year EPS (Basic) high stood at $0.98 for Q4 2021, and its period low was -$348.82 during Q1 2021.
  • Moreover, its 5-year median value for EPS (Basic) was -$1.1 (2024), whereas its average is -$23.87.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 383333.33% in 2022, then skyrocketed by 13454.55% in 2025.
  • Quarter analysis of 5 years shows GeneDx Holdings' EPS (Basic) stood at $0.98 in 2021, then plummeted by 3056.12% to -$28.97 in 2022, then skyrocketed by 96.82% to -$0.92 in 2023, then surged by 121.98% to $0.2 in 2024, then crashed by 233.52% to -$0.27 in 2025.
  • Its EPS (Basic) stands at -$0.27 for Q3 2025, versus $0.38 for Q2 2025 and -$0.23 for Q1 2025.